Clinical trials
Completed Myopia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
260 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 12 |
| 2009 | 11 |
| 2010 | 29 |
| 2011 | 12 |
| 2012 | 10 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 14 |
| 2016 | 5 |
| 2017 | 13 |
| 2018 | 26 |
| 2019 | 16 |
| 2020 | 14 |
| 2021 | 10 |
| 2022 | 16 |
| 2023 | 19 |
| 2024 | 10 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 260 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CooperVision, Inc. | 39 |
| Alcon Research | 38 |
| Bausch & Lomb Incorporated | 25 |
| Johnson & Johnson Vision Care, Inc. | 23 |
| Stanford University | 11 |
| Ohio State University | 6 |
| State University of New York College of Optometry | 6 |
| CooperVision International Limited (CVIL) | 5 |
| LENZ Therapeutics, Inc | 5 |
| Carl Zeiss Meditec, Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myopia | 260 |
| Astigmatism | 47 |
| Hyperopia | 40 |
| Refractive Errors | 39 |
| Presbyopia | 17 |
| Eye Diseases | 6 |
| Cataract | 3 |
| Asthenopia | 2 |
| Dry Eye Syndromes | 2 |
| Glaucoma | 2 |
Trials
Showing 1 to 25 of 260. Each trial links to its page on Pharma Observatory.
160 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.